·威尔布兰德因子通过形成中性粒细胞外细胞陷来加剧心力衰竭
Ge Mang1,2,3, Jianfeng Chen4, Ping Sun3
1Department of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China.
研究人员发现了一种新的VWF-SLC44A2-NET通路,导致心力衰竭的进展. 阻断这个轴,以及sacubitril/valsartan,通过改善心脏功能来治疗心力衰竭,显示出有前途.
科学领域:
- 心血管生物学 心血管生物学
- 免疫学 免疫学 免疫学
- 分子医学是分子医学.
背景情况:
- 心力衰竭 (HF) 是全球主要的死亡原因之一,结果不佳.
- 中性细胞外细胞陷 (NETs) 与心血管炎症有关,但它们在高血压中的作用尚不清楚.
- 这项研究研究了一种新的VWF-SLC44A2-NET轴在HF病变发生过程中.
研究的目的:
- 阐明VWF-SLC44A2-NET轴在心力衰竭中的作用.
- 探索NET参与HF的潜在机制.
- 评估针对这一轴的治疗潜力.
主要方法:
- 在人类HF患者和小鼠模型中测量了NET水平.
- 使用了遗传 (PAD4淘汰赛) 和药理的NET抑制.
- RNA测序和分子分析确定了上游调节者和下游影响.
- 再组合蛋白和淘汰赛被用来定义VWF-ADAMTS13-SLC44A2相互作用.
主要成果:
- 在HF患者和模型中发现了升高的NET水平.
- NET抑制和PAD4淘汰赛改善了心脏功能.
- 通过通过NE-TLR4.4抑制PGC-1α,NETs损害了心肌细胞的线粒体功能.
- 通过SLC44A2.2.进行VWF/ADAMTS13调节的NET形成.
- 萨库比特里尔/瓦尔沙坦增强了阻断VWF-SLC44A2-NET轴的益处.
结论:
- 一个新的VWF-SLC44A2-NET轴通过破坏线粒体平衡并促进细胞亡,为HF做出贡献.
- 准这一轴代表了心力衰竭的潜在治疗策略.
更多相关视频
09:59A High-throughput Assay to Assess and Quantify Neutrophil Extracellular Trap Formation
Published on: January 29, 2019
11:32Real-Time, High-Throughput Microscopic Quantification of Human Neutrophil Extracellular Trap Release and Assessing the Pharmacology of Antagonists
Published on: October 18, 2024
相关概念视频
Pathophysiology of Heart Failure
Intracellular Signaling Affects Focal Adhesions
Some...
Inflammation
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
